ALSO NOTED: Caraco gets tentative nod for Zyrtec copycat; Critical Therapeutics launches pulmonary med;

> Caraco Pharmaceutical Laboratories got the FDA's tentative approval to sell a chewable form of the allergy med Zyrtec, whose patent expires in December. Release

> Critical Therapeutics has launched an inhalation treatment for chronic obstructive pulmonary disease. Report

> Beijing Med-Pharm is expanding its senior management team with a new vice president Yanping Zhao, who will oversee all the company's Chinese subsidiaries and handle corporate strategy such as mergers and acquisitions. Report

> Coley Pharmaceutical Group has adopted a shareholder rights plan to protect itself from hostile takeover, saying the plan wasn't prompted by any current takeover attempt. Release

> Jazz Pharmaceuticals added Kohlberg Kravis Roberts & Co. Principal Nathaniel Zilkha to its board. Release

And Finally... What's in a drug name? Oh, $200,000 to $500,000 in consulting costs. Report